TWI780949B - Blood flow assessment method and system therefor - Google Patents

Blood flow assessment method and system therefor Download PDF

Info

Publication number
TWI780949B
TWI780949B TW110138209A TW110138209A TWI780949B TW I780949 B TWI780949 B TW I780949B TW 110138209 A TW110138209 A TW 110138209A TW 110138209 A TW110138209 A TW 110138209A TW I780949 B TWI780949 B TW I780949B
Authority
TW
Taiwan
Prior art keywords
subject
blood
data
change
standing
Prior art date
Application number
TW110138209A
Other languages
Chinese (zh)
Other versions
TW202315576A (en
Inventor
鮑建國
Original Assignee
弘光科技大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 弘光科技大學 filed Critical 弘光科技大學
Priority to TW110138209A priority Critical patent/TWI780949B/en
Application granted granted Critical
Publication of TWI780949B publication Critical patent/TWI780949B/en
Publication of TW202315576A publication Critical patent/TW202315576A/en

Links

Images

Abstract

一種血液流量評估方法,通過一血液回流系統檢測至少一受測者的血液,並包含下列步驟:獲取該至少一受測者在站立、平躺及再次站立時,去氧血紅蛋白濃度的變化,然後計算一靜脈血液回流量變化百分比,再根據該靜脈血液回流量變化百分比與一肌量標準範圍值,產生一相關於該至少一受測者的肌肉質量的評估結果。藉此,通過該受測者姿態的改變,提升計算該靜脈血液回流量之變化的確準性,不但可用於評估肌肉質量,且能夠降低設備成本。A blood flow assessment method, which detects the blood of at least one subject through a blood return system, and includes the following steps: obtaining the change of deoxygenated hemoglobin concentration of the at least one subject when standing, lying down and standing up again, and then A change percentage of venous blood return is calculated, and an evaluation result related to the muscle mass of the at least one subject is generated according to the change percentage of venous blood return and a muscle mass standard range. Thereby, through the change of the subject's posture, the accuracy of calculating the change of the venous blood return is improved, which can not only be used for evaluating muscle mass, but also reduce equipment cost.

Description

血液流量評估方法及其系統Blood flow assessment method and system thereof

本發明是有關於一種評估血液流量的方法,特別是指一種血液流量評估方法及其系統。 The present invention relates to a method for evaluating blood flow, in particular to a method for evaluating blood flow and a system thereof.

人體的「肌肉質量」會影響肌力和體能表現,當肌肉質量下降,不只走不快、站不起、提不重,更可能增加跌倒的風險。因此,醫師會根據肌肉質量、肌力表現,判斷是否為肌少症。 The "muscle mass" of the human body will affect muscle strength and physical performance. When muscle mass decreases, not only will it be difficult to walk fast, stand up, and lift heavy, but it may also increase the risk of falling. Therefore, doctors will judge whether it is sarcopenia based on muscle mass and muscle strength performance.

而評估肌肉的質量,最常使用的是雙能量X射線吸收儀,雖然功能多,但是,設備成本高、操作複雜,且受測者必須承擔一定的輻射劑量,而無法普及於一般醫療診所。 To evaluate muscle mass, dual-energy X-ray absorptiometry is most commonly used. Although it has many functions, the equipment is expensive, complicated to operate, and the subject must bear a certain radiation dose, so it cannot be popularized in general medical clinics.

因此,本發明之目的,即在提供一種使用操作簡易且成本低的血液流量評估方法及其系統。 Therefore, the object of the present invention is to provide a method and system for evaluating blood flow that is easy to use and low in cost.

於是,本發明血液流量評估方法,通過一血液回流系統檢測至少一受測者的血液,並包含下列步驟: Therefore, the blood flow assessment method of the present invention detects the blood of at least one subject through a blood return system, and includes the following steps:

(a)獲取一第一去氧數據,該第一去氧數據來自於該至少一受測者站立一第一時間的過程中,去氧血紅蛋白濃度的變化。 (a) Acquiring a first deoxygenation data, the first deoxygenation data comes from the change of the concentration of deoxygenated hemoglobin when the at least one subject stands for a first time.

(b)獲取一第二去氧數據,該第二去氧數據來自於該至少一受測者站立該第一時間後,平躺一第二時間的過程中,去氧血紅蛋白濃度的變化。 (b) Obtaining a second deoxygenation data, the second deoxygenation data comes from the change of deoxygenated hemoglobin concentration during the at least one subject lying down for a second time after standing for the first time.

(c)獲取一第三去氧數據,該第三去氧數據來自於該至少一受測者站立該第一時間、平躺該第二時間後,再次站立一第三時間的過程中,去氧血紅蛋白濃度的變化。 (c) Obtaining a third deoxygenation data, the third deoxygenation data comes from the at least one subject standing for the first time, lying down for the second time, and then standing again for a third time, to Changes in oxyhemoglobin concentration.

(d)根據公式(1):

Figure 110138209-A0305-02-0003-6
100%|,計算一靜脈血液回流量變化百分比。 (d) According to formula (1):
Figure 110138209-A0305-02-0003-6
100% |, calculate the percentage change of a venous return flow.

(e)根據該靜脈血液回流量變化百分比與一肌量標準範圍值,產生一相關於該至少一受測者的肌肉質量的評估結果。 (e) generating an evaluation result related to the muscle mass of the at least one subject according to the change percentage of venous return flow and a muscle mass standard range value.

一種執行所述血液回流量評估方法的血液流量評估系統,包含一倒立裝置、一氧飽和度測量裝置,及一評估裝置。 A blood flow evaluation system for implementing the blood return flow evaluation method includes an inverted device, an oxygen saturation measurement device, and an evaluation device.

該倒立裝置包括一適用於承載該至少一受測者的載體,該載體在一第一位置與一第二位置間轉動,在該第一位置時,該載體垂直於一平面,而適用於承載該至少一受測者位於站立狀態,在該第二位置時,該載體平行於該平面,而適用於承載該至少一受測者位於平躺狀態。 The inverted device includes a carrier suitable for carrying the at least one subject, the carrier rotates between a first position and a second position, in the first position, the carrier is perpendicular to a plane, and is suitable for carrying The at least one subject is in a standing state. In the second position, the carrier is parallel to the plane and is suitable for carrying the at least one subject in a lying state.

該氧飽和度測量裝置用於獲取該第一去氧數據、該第二 去氧數據、該第三去氧數據。 The oxygen saturation measuring device is used to obtain the first deoxygenation data, the second deoxygenation data, the third deoxygenation data.

該評估裝置與該氧飽和度測量裝置相互通訊,且用於計算該靜脈血液回流量變化百分比,及產生該評估結果。 The evaluating device communicates with the oxygen saturation measuring device, and is used for calculating the change percentage of the venous return flow and generating the evaluating result.

本發明之功效在於:通過該受測者姿態的改變,提升計算該靜脈血液回流量之變化的確準性,不但可用於評估肌肉質量,且能夠降低設備成本。 The effect of the present invention lies in: through the change of the subject's posture, the accuracy of calculating the change of the venous blood return is improved, which can not only be used for evaluating muscle mass, but also reduce equipment cost.

1:倒立裝置 1: Inversion device

11:支架 11: Bracket

12:載體 12: carrier

2:氧飽和度測量裝置 2: Oxygen saturation measuring device

3:評估裝置 3: Evaluation device

4:平面 4: Plane

D11:第一去氧數據 D11: First deoxygenation data

D12:第二去氧數據 D12: Second deoxygenation data

D13:第三去氧數據 D13: The third deoxygenation data

O21:第一含氧數據 O21: first oxygen data

O22:第二含氧數據 O22: the second oxygen content data

O23:第三含氧數據 O23: third oxygen data

D0:起始值 D 0 : initial value

Dmin:最小值 D min : minimum value

Omax:最大值 O max : maximum value

Omin:最小值 O min : minimum value

T1:第一時間 T1: the first time

T2:第二時間 T2: second time

T3:第三時間 T3: third time

t1_0:起始時間 t 1_0 : start time

t2_0:起始時間 t 2_0 : start time

t3_0:起始時間 t 3_0 : start time

本發明之其他的特徵及功效,將於參照圖式的實施方式中清楚地呈現,其中:圖1是一示意圖,說明本發明血液流量評估系統的一實施例;圖2是一示意圖,說明該實施例的一載體在一第一位置與一第二位置間轉動;圖3是該實施例的一流程圖;及圖4是一曲線圖,說明一去氧血紅蛋白濃度-時間曲線,及一含氧血紅蛋白濃度-時間曲線。 Other features and functions of the present invention will be clearly presented in the implementation manner with reference to the drawings, wherein: Fig. 1 is a schematic diagram illustrating an embodiment of the blood flow evaluation system of the present invention; Fig. 2 is a schematic diagram illustrating the present invention A carrier of the embodiment rotates between a first position and a second position; FIG. 3 is a flow chart of the embodiment; and FIG. 4 is a graph illustrating a deoxyhemoglobin concentration-time curve, and a Oxyhemoglobin concentration-time curve.

參閱圖1與圖2,本發明血液流量評估系統的一實施例,包含一倒立裝置1、一氧飽和度測量裝置2,及一評估裝置3。 Referring to FIG. 1 and FIG. 2 , an embodiment of the blood flow evaluation system of the present invention includes an inversion device 1 , an oxygen saturation measurement device 2 , and an evaluation device 3 .

該倒立裝置1包括一立置在一平面4的支架11,及一樞設在該支架11的載體12。該載體12適用於承載一受測者,且相對該支架11在一第一位置與一第二位置間轉動,在該第一位置時,該載體12實質上垂直於該平面4,而適用於承載該受測者位於站立狀態,在該第二位置時,該載體12實質上平行於該平面4或與該平面4夾一夾角,該夾角介於0度~15度,而適用於承載該受測者位於平躺狀態。 The inverted device 1 includes a support 11 standing on a plane 4 , and a carrier 12 pivotally mounted on the support 11 . The carrier 12 is suitable for carrying a subject, and rotates between a first position and a second position relative to the support 11. In the first position, the carrier 12 is substantially perpendicular to the plane 4, and is suitable for Carrying the subject in a standing state, when in the second position, the carrier 12 is substantially parallel to the plane 4 or forms an angle with the plane 4, the angle is between 0° and 15°, and is suitable for carrying the The subjects were placed in a supine position.

在本實施例中,該氧飽和度測量裝置2使用特定波長的光源,測定通過組織(如下肢)的光傳導強度,來計算血紅蛋白濃度、血氧飽和度(SO2)。其中,血紅蛋白濃度包括含氧血紅蛋白濃度(OxyHb)與去氧血紅蛋白濃度(DeoxyHb),量測的訊號取樣頻率為5Hz,分析軟體使用MoorVMS4.1版,進行即時量測。 In this embodiment, the oxygen saturation measuring device 2 uses a light source of a specific wavelength to measure the intensity of light transmission through tissues (such as lower extremities) to calculate hemoglobin concentration and blood oxygen saturation (SO 2 ). Among them, the hemoglobin concentration includes oxygenated hemoglobin concentration (OxyHb) and deoxygenated hemoglobin concentration (DeoxyHb). The sampling frequency of the measured signal is 5Hz. The analysis software uses MoorVMS version 4.1 for real-time measurement.

該評估裝置3與該氧飽和度測量裝置2相互通訊,且用於計算一靜脈血液回流量變化百分比,及產生一相關於該受測者的肌肉質量、血液循環效果的評估結果。 The evaluating device 3 communicates with the oxygen saturation measuring device 2 and is used to calculate a percentage change of venous return flow and generate an evaluation result related to the subject's muscle mass and blood circulation effect.

參閱圖1~圖4,本發明的血液回流量評估方法,通過該實施例的評估裝置3執行下列步驟: Referring to Fig. 1 ~ Fig. 4, the method for evaluating the blood return flow rate of the present invention, the following steps are performed through the evaluation device 3 of this embodiment:

步驟S01:獲取一第一去氧數據D11與一第一含氧數據O21。 Step S01: Obtain a first deoxygenation data D11 and a first oxygen content data O21.

該第一去氧數據D11來自於該氧飽和度測量裝置2測量 該受測者於一第一時間T1的過程中,去氧血紅蛋白濃度的變化,該第一含氧數據O21來自於該氧飽和度測量裝置2測量該受測者於該第一時間T1的過程中,含氧血紅蛋白濃度的變化。在本實施例中,是以該受測者被該載體12帶動至該第一位置,而呈站立的姿態的瞬間,為該第一時間T1的起始時間t1_0,且在該第一時間T1的過程中,都維持站立的姿態。 The first deoxygenated data D11 comes from the change of the deoxygenated hemoglobin concentration of the subject during a first time T1 measured by the oxygen saturation measuring device 2, and the first oxygenated data O21 comes from the oxygen saturation The degree measuring device 2 measures the change of the oxygenated hemoglobin concentration of the subject during the first time T1. In this embodiment, the moment when the subject is brought to the first position by the carrier 12 and assumes a standing posture is the starting time t 1_0 of the first time T1, and at the first time T1 In the process of T1, the standing posture was maintained.

步驟S02:獲取一第二去氧數據D12與一第二含氧數據O22。 Step S02: Obtain a second deoxygenation data D12 and a second oxygen content data O22.

該第二去氧數據D12來自於該氧飽和度測量裝置2測量該受測者於一第二時間T2的過程中,去氧血紅蛋白濃度的變化,該第二含氧數據O22來自於該氧飽和度測量裝置2測量該受測者於該第二時間T2的過程中,含氧血紅蛋白濃度的變化。在本實施例中,該第二時間T2緊接於該第一時間T1之後,是以該受測者被該載體12帶動,由該第一位置變化至該第二位置,而呈平躺的姿態的瞬間,為該第二時間T2的起始時間t2_0,且在該第二時間T2的過程中,都維持平躺的姿態。 The second deoxygenated data D12 comes from the change of the deoxygenated hemoglobin concentration of the subject during a second time T2 measured by the oxygen saturation measuring device 2, and the second oxygenated data O22 comes from the oxygen saturation The degree measuring device 2 measures the change of the oxygenated hemoglobin concentration of the subject during the second time T2. In this embodiment, the second time T2 is immediately after the first time T1, so that the subject is driven by the carrier 12, changes from the first position to the second position, and lies flat The moment of the posture is the start time t 2 — 0 of the second time T2 , and the lying down posture is maintained during the second time T2.

步驟S03:獲取一第三去氧數據D13與一第三含氧數據O23。 Step S03: Obtain a third deoxygenation data D13 and a third oxygen content data O23.

該第三去氧數據D13來自於該氧飽和度測量裝置2測量該受測者於一第三時間T3的過程中,去氧血紅蛋白濃度的變化,該 第三含氧數據O23來自於該氧飽和度測量裝置2測量該受測者於該第三時間T3的過程中,含氧血紅蛋白濃度的變化。在本實施例中,該第三時間T3緊接於該第二時間T2之後,是以該受測者被該載體12帶動,由該第二位置再次變化至該第一位置,而呈站立的姿態的瞬間,為該第三時間T3的起始時間t3_0,且在該第三時間T3的過程中,都維持站立的姿態。 The third deoxygenated data D13 comes from the oxygen saturation measuring device 2 measuring the change of the deoxygenated hemoglobin concentration of the subject during a third time T3, and the third oxygenated data O23 comes from the oxygen saturation The degree measuring device 2 measures the variation of the oxygenated hemoglobin concentration of the subject during the third time T3. In this embodiment, the third time T3 is immediately after the second time T2, so that the subject is driven by the carrier 12, changes from the second position to the first position again, and is standing The moment of posture is the start time t 3 — 0 of the third time T3 , and during the third time T3, the standing posture is maintained.

值得說明的是,該第一時間T1=該第二時間T2=該第三時間T3=5分鍾。 It is worth noting that the first time T1=the second time T2=the third time T3=5 minutes.

步驟S04:根據公式(1)計算一靜脈血液回流量變化百分比△HHb(%)。 Step S04: Calculate a percentage change of venous blood return flow rate ΔHHb(%) according to formula (1).

Figure 110138209-A0305-02-0007-3
Figure 110138209-A0305-02-0007-3

值得說明的是,該第二去氧數據D12的起始值D0相當於在該起始時間t2_0所獲取的去氧血紅蛋白濃度。參閱圖4,舉例來說,該第二去氧數據D12的最小值Dmin=100、該第二去氧數據D12的起始值D0=167,則該靜脈血液回流量變化百分比△HHb(%)=|

Figure 110138209-A0305-02-0007-4
。 It should be noted that the initial value D 0 of the second deoxygenation data D12 corresponds to the concentration of deoxygenated hemoglobin obtained at the initial time t 2 — 0 . Referring to FIG. 4 , for example, the minimum value D min of the second deoxygenation data D12 =100, and the initial value D 0 of the second deoxygenation data D12 =167, then the percentage change of the venous blood return flow ΔHHb( %)=|
Figure 110138209-A0305-02-0007-4
.

步驟S05:根據該受測者的身高,獲得一血壓差△P。 Step S05: Obtain a blood pressure difference ΔP according to the subject's height.

值得說明的是,該血壓差△P來自於身高從頭到量測部位的高度差所造成的淨水壓差,而正比於身高。在本實施例中,是以 查表的方式,獲得該血壓差△P。 It is worth noting that the blood pressure difference △P comes from the net water pressure difference caused by the height difference from the head to the measurement site, and is proportional to the height. In this example, the The blood pressure difference △P is obtained by looking up the table.

步驟S06:根據公式(2)計算一動脈血液輸入阻力。 Step S06: Calculate an arterial blood input resistance according to formula (2).

Figure 110138209-A0305-02-0008-7
Figure 110138209-A0305-02-0008-7

參閱圖4,舉例來說,該第三含氧數據O23的最大值Omax=250、該第二含氧數據O22的最小值Omin=200、該第一含氧數據O21倒數30秒的平均值=200、血壓差△P約為92.6mmHg,則

Figure 110138209-A0305-02-0008-8
。 Referring to FIG. 4 , for example, the maximum value O max =250 of the third oxygen content data O23, the minimum value O min =200 of the second oxygen content data O22, and the average of the last 30 seconds of the first oxygen content data O21 value=200, blood pressure difference △P is about 92.6mmHg, then
Figure 110138209-A0305-02-0008-8
.

步驟S06:根據該靜脈血液回流量變化百分比△HHb(%)與一肌量標準範圍值H0,及根據該動脈血液輸入阻力R與一阻力標準範圍值R0,產生一相關於該受測者的肌肉質量與血液循環效果的評估結果。 Step S06: According to the change percentage of venous blood return flow ΔHHb(%) and a standard range value H 0 of muscle mass, and according to the arterial blood input resistance R and a standard range value R 0 of resistance, generate a correlation with the measured The evaluation results of muscle mass and blood circulation effect of patients.

在本實施例中,該肌量標準範圍值H0為各年齡層之受測者的靜脈血液回流量變化百分比△HHb(%)的平均值,該阻力標準範圍值R0也是為各年齡層之受測者的動脈血液輸入阻力的平均值,介於368~598。 In this embodiment, the muscle mass standard range value H0 is the average value of the change percentage ΔHHb (%) of the venous blood return flow rate of subjects of each age group, and the resistance standard range value R0 is also the average value of each age group The average value of arterial blood input resistance of the subjects ranged from 368 to 598.

由於肌肉組織內的血管密度與血液含量應該與肌肉質量同步增減,也就是肌肉組織內的含血量與肌肉組織的體積成正比,因此,當該靜脈血液回流量變化百分比△HHb(%)<該肌量標準範圍值H0時,表示肌肉組織內的「有效血液量」低,該評估結果會呈 現肌肉質量異常(偏低)。 Since the blood vessel density and blood content in the muscle tissue should increase and decrease synchronously with the muscle mass, that is, the blood content in the muscle tissue is proportional to the volume of the muscle tissue. Therefore, when the venous blood return flow rate change percentage △HHb(%) When < the muscle mass standard range value H 0 , it means that the "effective blood volume" in the muscle tissue is low, and the evaluation result will show abnormal (low) muscle mass.

當該動脈血液輸入阻力>該阻力標準範圍值R0時,表示受測者下肢肌肉組織內的血管阻力較大,導致下肢的含氧血量因為該受測者由站立姿態變化至平躺姿態,含氧血紅蛋白濃度不易下降,再由平躺姿態變化至站立姿態的過程中,含氧血紅蛋白濃度上升不易,換句話說,該評估結果會呈現血液循環動脈血液輸入阻力異常的評估結果。 When the arterial blood input resistance > the resistance standard range value R0, it means that the vascular resistance in the muscular tissue of the lower limbs of the subject is relatively large, resulting in the oxygenated blood volume of the lower limbs. Because the subject changes from a standing posture to a lying posture, The concentration of oxygenated hemoglobin is not easy to drop, and it is not easy to increase the concentration of oxygenated hemoglobin when changing from a lying posture to a standing posture. In other words, the evaluation result will show the evaluation result of abnormal blood input resistance of blood circulation arteries.

藉此,該評估結果可用於評估肌少症的可能性,或用於評估心血管疾病的風險高低,但要注意的是,該評估結果不涉及醫療診斷,實務上,判斷是否為肌少症、或判斷是否為心血管症病的高風險群,仍需由醫師進行診斷。 In this way, the evaluation results can be used to assess the possibility of sarcopenia, or to assess the risk of cardiovascular disease, but it should be noted that the evaluation results do not involve medical diagnosis. In practice, it is necessary to judge whether it is sarcopenia , or to judge whether it is a high-risk group of cardiovascular diseases, it still needs to be diagnosed by a physician.

經由以上的說明,可將前述實施例的優點歸納如下: Through the above description, the advantages of the aforementioned embodiments can be summarized as follows:

1、本發明通過計算靜脈回流量變化百分比△HHb(%)可以準確計算組織內的「有效血液量」,從而得知肌肉質量。顯然,本發明可以通過簡單的設備,及該受測者姿態的改變,測得的組織含血量,不但成本低、使用操作容易,且不會受到受測部位靜脈曲張或是水腫的干擾。 1. The present invention can accurately calculate the "effective blood volume" in the tissue by calculating the change percentage of venous return flow △HHb(%), so as to know the muscle mass. Apparently, the present invention can measure the blood content of the tissue through simple equipment and the change of the subject's posture, which is not only low in cost, easy to use and operate, but also not disturbed by varicose veins or edema at the test site.

2、另外,通過該受測者姿態的改變,還能夠在進一步測知動脈血液輸入阻力與調整的能力,而用於評估心血管疾病的風險高低。 2. In addition, through the change of the subject's posture, it is also possible to further measure the arterial blood input resistance and the ability to adjust, so as to evaluate the risk of cardiovascular disease.

惟以上所述者,僅為本發明之實施例而已,當不能以此限定本發明實施之範圍,凡是依本發明申請專利範圍及專利說明書內容所作之簡單的等效變化與修飾,皆仍屬本發明專利涵蓋之範圍內。 But what is described above is only an embodiment of the present invention, and should not limit the scope of the present invention. All simple equivalent changes and modifications made according to the patent scope of the present invention and the content of the patent specification are still within the scope of the present invention. Within the scope covered by the patent of the present invention.

1:倒立裝置 1: Inversion device

11:支架 11: Bracket

12:載體 12: carrier

2:氧飽和度測量裝置 2: Oxygen saturation measuring device

3:評估裝置 3: Evaluation device

Claims (9)

一種血液回流量評估方法,通過一血液回流系統檢測至少一受測者的血液,並執行下列步驟:(a)獲取一第一去氧數據,該第一去氧數據來自於該至少一受測者站立一第一時間的過程中,去氧血紅蛋白濃度的變化;(b)獲取一第二去氧數據,該第二去氧數據來自於該至少一受測者站立該第一時間後,平躺一第二時間的過程中,去氧血紅蛋白濃度的變化;(c)獲取一第三去氧數據,該第三去氧數據來自於該至少一受測者站立該第一時間、平躺該第二時間後,再次站立一第三時間的過程中,去氧血紅蛋白濃度的變化;(d)根據公式(1):
Figure 110138209-A0305-02-0012-9
100%|,計算一靜脈血液回流量變化百分比;及(e)根據該靜脈血液回流量變化百分比與一肌量標準範圍值,產生一相關於該至少一受測者的肌肉質量的評估結果。
A method for assessing blood return flow, which comprises detecting the blood of at least one subject through a blood return system, and performing the following steps: (a) acquiring a first deoxygenation data, the first deoxygenation data comes from the at least one subject During the process of the subject standing for a first time, the change of the deoxyhemoglobin concentration; (b) obtaining a second deoxygenation data, the second deoxygenation data comes from the average of the at least one subject standing for the first time During the process of lying down for a second time, the change of deoxygenated hemoglobin concentration; (c) obtaining a third deoxygenation data, the third deoxygenation data comes from the at least one subject standing for the first time, lying down for the After the second time, during the process of standing again for a third time, the change of deoxygenated hemoglobin concentration; (d) according to formula (1):
Figure 110138209-A0305-02-0012-9
100%|, calculating a percentage change of venous blood return; and (e) generating an evaluation result related to the muscle mass of the at least one subject according to the percentage change of venous blood return and a muscle mass standard range value.
如請求項1所述的血液回流量評估方法,其中,該第二去氧數據的起始值來自於該至少一受測者由站立變化至平躺時,第0秒的去氧血紅蛋白濃度。 The blood return flow assessment method according to claim 1, wherein the initial value of the second deoxygenation data comes from the deoxygenated hemoglobin concentration at second 0 when the at least one subject changes from standing to lying down. 如請求項1所述的血液回流量評估方法,用於評估數受測者的肌肉質量,其中,該肌量標準範圍值為各年齡層之受測者的靜脈血液回流量變化百分比的平均值。 The method for assessing blood return flow as described in Claim 1 is used to evaluate the muscle mass of several subjects, wherein the muscle mass standard range value is the average value of the percentage change of venous return flow of subjects of each age group . 如請求項3所述的血液流量評估方法,其中,當該靜脈 血液回流量變化百分比<該肌量標準範圍值時,產生代表異常的評估結果。 The blood flow assessment method as described in claim 3, wherein, when the vein When the percentage change of blood return flow is less than the standard range value of muscle mass, an evaluation result representing abnormality is produced. 如請求項1所述的血液回流量評估方法,其中,在步驟(a)時,還進一步獲取一第一含氧數據,該第一含氧數據來自於該至少一受測者站立該第一時間的過程中,含氧血紅蛋白濃度的變化,在步驟(b)時,還進一步獲取一第二含氧數據,該第二含氧數據來自於該至少一受測者站立該第二時間的過程中,含氧血紅蛋白濃度的變化,在步驟(c)時,還進一步獲取一第三含氧數據,該第三含氧數據來自於該至少一受測者站立該第三時間的過程中,含氧血紅蛋白濃度的變化。 The method for assessing blood return flow rate according to claim 1, wherein, in step (a), a first oxygen content data is further acquired, and the first oxygen content data comes from the at least one subject standing on the first In the process of time, the change of oxygenated hemoglobin concentration, in step (b), a second oxygen content data is further obtained, and the second oxygen content data comes from the process of the at least one subject standing for the second time In the change of oxygenated hemoglobin concentration, in step (c), a third oxygen content data is further obtained, and the third oxygen content data comes from the process of the at least one subject standing for the third time, including Changes in oxyhemoglobin concentration. 如請求項5所述的血液回流量評估方法,還包含在步驟(d)後的下列步驟:(f)根據該受測者的身高,獲得一血壓差;及(g)根據公式(2):該血壓差=
Figure 110138209-A0305-02-0013-10
,計算該動脈血液輸入阻力;且步驟(e)還進一步根據該動脈血液輸入阻力與一阻力標準範圍值,產生該相關於該至少一受測者的血液循環效果的評估結果。
The method for assessing blood return as described in claim 5, further comprising the following steps after step (d): (f) obtaining a blood pressure difference according to the height of the subject; and (g) according to formula (2) : The blood pressure difference =
Figure 110138209-A0305-02-0013-10
, calculating the arterial blood input resistance; and step (e) is further based on the arterial blood input resistance and a resistance standard range value, generating the evaluation result related to the blood circulation effect of the at least one subject.
如請求項6所述的血液回流量評估方法,其中,當該動脈血液輸入阻力>該阻力標準範圍值時,產生代表異常的評估結果。 The blood return flow assessment method according to Claim 6, wherein when the arterial blood input resistance is greater than the resistance standard range value, an assessment result representing abnormality is generated. 一種執行如請求項1~4任一項所述的血液回流量評估方 法的血液流量評估系統,包含:一倒立裝置,包括一適用於承載該至少一受測者的載體,該載體在一第一位置與一第二位置間轉動,在該第一位置時,該載體垂直於一平面,而適用於承載該至少一受測者位於站立狀態,在該第二位置時,該載體平行於該平面,而適用於承載該至少一受測者位於平躺狀態;一氧飽和度測量裝置,適配於該倒立裝置,且用於獲取該第一去氧數據、該第二去氧數據、該第三去氧數據;及一評估裝置,適配於該倒立裝置,且與該氧飽和度測量裝置相互通訊,且用於計算該靜脈血液回流量變化百分比,及產生該評估結果。 A method for evaluating blood return flow as described in any one of request items 1 to 4 A blood flow assessment system according to the method, comprising: an inverted device, including a carrier suitable for carrying the at least one subject, the carrier rotates between a first position and a second position, when in the first position, the The carrier is perpendicular to a plane and is suitable for carrying the at least one subject in a standing state, and in the second position, the carrier is parallel to the plane and is suitable for carrying the at least one subject in a lying state; an oxygen saturation measuring device adapted to the inverted device and used to obtain the first deoxygenation data, the second deoxygenated data, and the third deoxygenated data; and an evaluation device adapted to the inverted device, And it communicates with the oxygen saturation measuring device, and is used to calculate the change percentage of the venous blood return flow, and generate the evaluation result. 一種執行如請求項6所述的血液回流量評估方法的血液流量評估系統,包含:一倒立裝置,包括一適用於承載該至少一受測者的載體,該載體在一第一位置與一第二位置間轉動,在該第一位置時,該載體垂直於一平面,而適用於承載該至少一受測者位於站立狀態,在該第二位置時,該載體平行於該平面,而適用於承載該至少一受測者位於平躺狀態;一氧飽和度測量裝置,適配於該倒立裝置,且用於獲取該第一去氧數據、該第二去氧數據、該第三去氧數據、該第一含氧數據、該第二含氧數據、該第三含氧數 據;及一評估裝置,適配於該倒立裝置,且與該氧飽和度測量裝置相互通訊,且根據該受測者的身高,獲得該血壓差,及用於計算該靜脈血液回流量變化百分比、該動脈血液輸入阻力,及產生該評估結果。 A blood flow assessment system for performing the blood return flow assessment method described in claim 6, comprising: an inverted device, including a carrier suitable for carrying the at least one subject, the carrier is in a first position and a first Rotate between two positions, in the first position, the carrier is perpendicular to a plane, and is suitable for carrying the at least one subject in a standing state; in the second position, the carrier is parallel to the plane, and is suitable for carrying Carrying the at least one subject in a lying state; an oxygen saturation measuring device, adapted to the inverted device, and used to acquire the first deoxygenation data, the second deoxygenation data, and the third deoxygenation data , the first oxygen data, the second oxygen data, the third oxygen data and an evaluation device, which is adapted to the inversion device and communicates with the oxygen saturation measurement device, and obtains the blood pressure difference according to the height of the subject, and is used to calculate the percentage change of the venous return flow , the arterial blood input resistance, and generate the evaluation result.
TW110138209A 2021-10-14 2021-10-14 Blood flow assessment method and system therefor TWI780949B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW110138209A TWI780949B (en) 2021-10-14 2021-10-14 Blood flow assessment method and system therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW110138209A TWI780949B (en) 2021-10-14 2021-10-14 Blood flow assessment method and system therefor

Publications (2)

Publication Number Publication Date
TWI780949B true TWI780949B (en) 2022-10-11
TW202315576A TW202315576A (en) 2023-04-16

Family

ID=85462725

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110138209A TWI780949B (en) 2021-10-14 2021-10-14 Blood flow assessment method and system therefor

Country Status (1)

Country Link
TW (1) TWI780949B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090018405A1 (en) * 2007-07-13 2009-01-15 Astem Corporation Exercise load measuring device
CN107595294A (en) * 2017-09-06 2018-01-19 深圳先进技术研究院 Detect method, apparatus, equipment and the storage medium of function of deglutition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090018405A1 (en) * 2007-07-13 2009-01-15 Astem Corporation Exercise load measuring device
CN107595294A (en) * 2017-09-06 2018-01-19 深圳先进技术研究院 Detect method, apparatus, equipment and the storage medium of function of deglutition

Also Published As

Publication number Publication date
TW202315576A (en) 2023-04-16

Similar Documents

Publication Publication Date Title
Shabani Varaki et al. Peripheral vascular disease assessment in the lower limb: a review of current and emerging non-invasive diagnostic methods
JP5057783B2 (en) System or method for assessing peripheral blood circulation in a subject
Foo et al. Pulse transit time as an indirect marker for variations in cardiovascular related reactivity
JP7311424B2 (en) Systems and methods for assessing diabetic circulatory complications
Nygren et al. Detection of changes in muscle oxygen saturation in the human leg: a comparison of two near-infrared spectroscopy devices
Azzopardi et al. Agreement of clinical tests for the diagnosis of peripheral arterial disease
JP6203737B2 (en) Finger arteriole dilatability testing method, finger arteriole dilatability testing device, and finger arteriole dilatability testing program
US20140316291A1 (en) Measurement device, evaluating method, and evaluation program
van Hooff et al. Test–retest reliability of skeletal muscle oxygenation measurement using near‐infrared spectroscopy during exercise in patients with sport‐related iliac artery flow limitation
Zhang et al. The effect of local mild cold exposure on pulse transit time
Tanaka et al. Accuracy assessment of a noninvasive device for monitoring beat-by-beat blood pressure in the radial artery using the volume-compensation method
PT1150604E (en) Method and device for continuous analysis of cardiovascular activity of a subject
Nandi et al. A novel cnn-lstm model based non-invasive cuff-less blood pressure estimation system
van Hooff et al. Near-infrared spectroscopy is promising to detect iliac artery flow limitations in athletes: a pilot study
TWI780949B (en) Blood flow assessment method and system therefor
Bundó et al. Measurement of the ankle brachial index with a non-mercury sphygmomanometer in diabetic patients: a concordance study
VOWDEN Understanding the ankle brachial pressure index to treat venous ulceration.
US20140243691A1 (en) Measurement device, index calculating method, and index calculating program
RU2236816C1 (en) Method for integral evaluating peripheral circulation of distal departments in lower limbs
WO2023176324A1 (en) Lower extremity vascular lesion evaluation device and lower extremity vascular lesion evaluation method
US20160206218A1 (en) Biological Tissue Diagnosis Apparatus and Method
CN110113991B (en) Apparatus, system and method for obtaining hemodynamic data for an individual
Harwood et al. Exercise testing in peripheral arterial disease
Foo Bilateral transit time assessment of upper and lower limbs as a surrogate ankle brachial index marker
van Hooff et al. Research Article Near-Infrared Spectroscopy Is Promising to Detect Iliac Artery Flow Limitations in Athletes: A Pilot Study

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent